Evidence map›Paper›PMID 34151409›Full record

ArticleJournal of molecular neuroscience : MN2021

miR-128 as a Regulator of Synaptic Properties in 5xFAD Mice Hippocampal Neurons.

Inna Shvarts-Serebro, Anton Sheinin, Irit Gottfried, Lior Adler, Nofar Schottlender, Uri Ashery, Boaz Barak

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular neuroscience : MN, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. The Role of miR-128 in Neurodegenerative Diseases.International journal of molecular sciences · 2023
    Review
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Inna Shvarts-SerebroThe Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
Anton SheininThe Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
Irit GottfriedThe School of Neurobiology, Biochemistry and Biophysics, Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Lior AdlerThe Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
Nofar SchottlenderThe Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
Uri AsheryThe Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel. uriashery@gmail.com.ORCID http://orcid.org/0000-0001-6338-7888
Boaz BarakThe Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel. boazba@tauex.tau.ac.il.ORCID http://orcid.org/0000-0001-9724-4578

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is characterized by progressive synaptic dysfunction, deterioration of neuronal transmission, and consequently neuronal death. Although there is no treatment for AD, exposure to enriched environment (EE) in mice, as well as physical and mental activity in human subjects have been shown to have a protective effect by slowing the disease's progression and reducing AD-like cognitive impairment. However, the molecular mechanism of this mitigating effect is still not understood. One of the mechanisms that has recently been shown to be involved in neuronal degeneration is microRNAs (miRNAs) regulation, which act as a post-transcriptional regulators of gene expression. miR-128 has been shown to be significantly altered in individuals with AD and in mice following exposure to EE. Here, we focused on elucidating the possible role of miR-128 in AD pathology and found that miR-128 regulates the expression of two proteins essential for synaptic transmission, SNAP-25, and synaptotagmin1 (Syt1). Clinically relevant, in 5xFAD mouse model for AD, this miRNA's expression was found as downregulated, resembling the alteration found in the hippocampi of individuals with AD. Interestingly, exposing WT mice to EE also resulted in downregulation of miR-128 expression levels, although EE and AD conditions demonstrate opposing effects on neuronal functioning and synaptic plasticity. We also found that miR-128 expression downregulation in primary hippocampal cultures from 5xFAD mice results in increased neuronal network activity and neuronal excitability. Altogether, our findings place miR-128 as a synaptic player that may contribute to synaptic functioning and plasticity through regulation of synaptic protein expression and function.

Indexed as

Alzheimer DiseaseAnimalsCells, CulturedHippocampusMiceMicroRNAsNeuronsSynapsesSynaptosomal-Associated Protein 25Synaptotagmin IMicroRNAsMirn128 microRNA, mouseSynaptosomal-Associated Protein 25Synaptotagmin ISyt1 protein, mouseAlzheimer’s diseasemiR-128Neuronal activitySNAP-25Synaptotagmin1

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.